Posted on March 11, 2021
By Rasha AbouNayef | AstraZeneca, Gender Diversity Project Lead MEA
January 27, 2021
By Soo Bang | Bristol-Myers Squibb, Vice president, Enterprise Integration Lead
As we look back on 2020, I am in awe of how much we have accomplished at Bristol Myers Squibb (BMS), especially when it comes to creating a positive environment to develop and enable female leaders across our global company. The last year was a year of significant transition for many of our colleagues, myself […]
April 13, 2021
By Natalie Hosea | Takeda, California Site Head & Head of DMPK in San Diego
April 8, 2021
By Deepak Khanna | MSD, President Human Health, Europe & Canada
February 23, 2021
By Mahender Nayak | Takeda, Senior VP/Head of ICMEA Region (India, Turkey, CIS countries, Middle East and Africa)
February 1, 2021
By Emmanuelle Quiles | Janssen, Europe, Middle East & Africa, President France
January 11, 2021
By Pius S. Hornstein MSc PhD | Sanofi, General Manager & Country Lead
April 15, 2021
By Zwelethu Bashman | MSD, Managing Director SA & SSA
January 13, 2021
By Anand Narasimhan | Merck Specialties Pvt LTD, Managing Director
February 3, 2021
By Susan King-Barnardo | Merck Group, Manging Director – Greece
January 25, 2021
By Agnes Ho | Roche Diagnostics, Head of Sub-Region Two, Developed Growth Markets, Asia Pacific
April 6, 2021
By Peggy Wu | Abbvie, Vice President Asia
February 8, 2021
By Jörg Rupp | Roche, Head of Roche Pharma International (I7)
January 18, 2021
By Michaela Hrdlickova | Biogen, Director Patient Advocacy Europe/Canada/Partner Markets, SMA
